Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.51 which represents a decrease of $-0.36 or -1.17% from the prior close of $30.87. The stock opened at $29.28 and touched a low ...
The global robotic surgery market is growing rapidly, driven by technological advancements, particularly in artificial ...
Citi lowered the firm’s price target on Amgen (AMGN) to $295 from $310 and keeps a Neutral rating on the shares. Ahead of the ...
Boeing (BA) reported a wider core loss than anticipated. General Motors (GM) reported stronger-than-forecast earnings, while Kleenex tissue maker Kimberly-Clark (KMB) reported weaker-than-expected ...
Ida Liu, the global head of Citi's private banking arm, announces her departure amid the bank's focus on expanding its wealth ...
A slew of stocks, including chip maker Nvidia, fell Monday after Chinese startup DeepSeek released an AI model that runs on less-advanced chips and at a lower cost than U.S. rivals.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
Nvidia stock is set for its worst trading day in recent history — however, two Wall Street analysts remain bullish, despite ...
Citi analyst Atif Malik says DeepSeek’s R1, a China-made large language model, prompted investor concerns around the cost of compute as it ...
Citi analyst Geoff Meacham maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday ...
Buffett's financial stocks include major holdings such as American Express and Bank of America. Jefferies Financial has been ...
Citigroup's double-digit ROTCE target is more achievable after Q4 improvements. Read why C stock could deliver attractive ...